Keyphrases
Obesity
100%
Glucagon-like
74%
Type 2 Diabetes Mellitus (T2DM)
66%
Glucagon
43%
Leptin
40%
Metabolic Disease
37%
Pharmacology
34%
Energy Expenditure
32%
Obesity Treatment
30%
Food Intake
28%
Diabetes Management
27%
Glucose Metabolism
26%
Diet-induced Obesity
26%
Unimolecular
25%
Glucose-dependent Insulinotropic Polypeptide
25%
Bariatric Surgery
23%
Energy Homeostasis
22%
Glucagon-like peptide-1 (GLP-1)
21%
Diet-induced Obese Mice
21%
Fibroblast Growth Factor 21 (FGF21)
21%
Agonism
20%
Diabetes
20%
Growth Differentiation factor-15 (GDF-15)
20%
Melanocortin 4 Receptor (MC4R)
20%
GPRC6A
20%
Rodents
18%
Treatment Options
18%
Dyslipidemia
17%
Metabolic Disorders
16%
Liraglutide
16%
Adiposity
16%
Glucagon Receptor
16%
Obese Mice
15%
Medicine and Dentistry
Glucagon Like Peptide 1
62%
Glucagon
50%
Diet Induced Obesity
48%
Receptor
38%
Leptin
32%
Body Weight
25%
Water-Electrolyte Imbalance
24%
Homeostasis
24%
Maturity Onset Diabetes of the Young
23%
Metabolic Disorder
21%
Bariatric Surgery
21%
Food Intake
20%
Arginine
20%
Gastric Inhibitory Polypeptide
20%
Dexamethasone
20%
Energy Expenditure
19%
Incretin
17%
Diabetes
17%
Glucagon Like Peptide 1 Receptor
16%
Obesity
15%
Fatty Liver
15%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon-Like Peptide-1
83%
Non Insulin Dependent Diabetes Mellitus
59%
Receptor
54%
Diseases
52%
Glucagon
37%
Diet Induced Obesity
32%
Arginine
26%
Obesity
23%
Dexamethasone
20%
Gastric Inhibitory Polypeptide
18%
Liraglutide
18%
Incretin
18%
Glucagon-Like Peptide 1 Receptor
16%
Amino Acid
16%
Glucagon Receptor
16%
Pharmacotherapy
15%
Mouse Mutant
15%
Polypharmacy
15%
